Our perspectives and foresight

We heard resoundingly from our pharma partners that they’re looking to AI and automation to meet productivity demands this year. But, what does adoption of AI tools really look like for this audience? We engaged with 25 pharma leaders to better understand their goals, challenges, and operational needs. Here’s a summary of what we learned.

Multiomics is widely regarded as key to understanding the complexity of biology, but how important is it to align on a singular definition of multiomics?

For our 2024 State of Science update, we heard from nearly 400 scientists on topics that span which technologies they'll be purchasing this year, their economic outlook, and their intent to collaborate with external partners.

To serve clients and leaders we work with, the LINUS team identifies patterns and trends that we believe will impact the scientific community and beyond.

This year’s HLTH 2019 conference was abuzz with the exciting frontiers of healthcare. Yet there was a deafening silence in three key areas that we think could have an even bigger impact on the future of health if we add them into the folds of our conversations.

In our semi-annual State of Science survey, we look into how scientists around the globe continue to adapt their priorities, productivity, and mindset, and how that may affect the life science industry. For the second half of 2023, we’re in a unique moment where there are immediate opportunities. LINUS CEO Hamid Ghanadan and DeciBio Partner Stephane Budel share market insights and answer your questions about the state of the industry.

Innovators, policy makers, physicians, researchers, investors and thought leaders all came together at Aspen Ideas Festival to discuss their bold approaches to better the future of health. This year, there was a resonant call for leaders to embrace a sense of urgency to change health outcomes this year — and to do so requires action that will drive that change.

The Linus Group (LINUS) today announced the hiring of Dr. Natalie LaFranzo, PhD to the role of Vice President of Strategy. Natalie joins Hamid Ghanadan (founder and CEO) and Kristin Apple (President) as members of the LINUS leadership team.

The Linus Group (LINUS) today announced the hiring of Dr. Natalie LaFranzo, PhD to the role of Vice President of Strategy. Natalie joins Hamid Ghanadan (founder and CEO) and Kristin Apple (President) as members of the LINUS leadership team.

The LINUS team explored digital health technologies—like wearables, at-home diagnostics, and applications—to understand the evolving landscape. From this research, we identified three foundational pillars for building relationships with consumers who are increasingly using digital health solutions to optimize their well-being.